When Privacy Is the Product: How Albus Health Is Redefining What Clinical Trials Can Measure at Home
A contactless device, 40 countries, and a design philosophy that starts with patients — not compliance checklists The question...
Diana Andrade
“Minutes, Not Days”: Site-Centric AI and Clinical Trial Experience
The coordinator stared at a 400-page EHR export, convinced the week was lost—until an AI pre-screen flagged 23 likely-eligible...
How Small Biotechs Navigate Clinical Trial Vendor Oversight
At SCOPE Europe 2025, a panel on vendor identification, selection, and management highlighted a pragmatic blueprint for small biopharma:...
First UK GDPR Fine on Processor: ICO Targets Vendors
The UK Information Commissioner’s Office (ICO) has recently fined Advanced Computer Software Group Ltd £3.07 million for breaching the...
Understanding DPIAs in Clinical Research
Under the EU General Data Protection Regulation (GDPR), a Data Protection Impact Assessment (DPIA) is required when data processing...
Argentina Fines Ferring: Privacy Wake-Up Call for Pharma
In a precedent-setting decision, Argentina’s Data Protection Authority (Agencia de Acceso a la Información Pública – AAIP) has fined...
Privacy by Design in Global Clinical Trials
Multinational clinical trials are crucial for advancing medical innovation and improving patient outcomes. By including diverse populations, they provide...
Synthetic Data: A Real Fix for Clinical Trials?
The industry loves to celebrate synthetic data as a privacy solution—but where’s the real impact? Let’s be clear: privacy...
GDPR and Cross-Border Data Transfers in Clinical Trials
Cross-border data transfers are a critical yet complex aspect in clinical trials. With global collaborations becoming the norm, personal...
Ensuring Data Security Throughout the Trial Lifecycle
Clinical trials rely on robust data security measures to protect sensitive participant information, including personally identifiable information (PII) and...